Blondeaux, A.; Valibouze, C.; Speca, S.; Rousseaux, C.; Dubuquoy, C.; Blanquart, H.; Zerbib, P.; Desreumaux, P.; Foligné, B.; Titécat, M.
Changes in HLA-B27 Transgenic Rat Fecal Microbiota Following Tofacitinib Treatment and Ileocecal Resection Surgery: Implications for Crohn’s Disease Management. Int. J. Mol. Sci. 2024, 25, 2164.
https://doi.org/10.3390/ijms25042164
AMA Style
Blondeaux A, Valibouze C, Speca S, Rousseaux C, Dubuquoy C, Blanquart H, Zerbib P, Desreumaux P, Foligné B, Titécat M.
Changes in HLA-B27 Transgenic Rat Fecal Microbiota Following Tofacitinib Treatment and Ileocecal Resection Surgery: Implications for Crohn’s Disease Management. International Journal of Molecular Sciences. 2024; 25(4):2164.
https://doi.org/10.3390/ijms25042164
Chicago/Turabian Style
Blondeaux, Aurélie, Caroline Valibouze, Silvia Speca, Christel Rousseaux, Caroline Dubuquoy, Hélène Blanquart, Philippe Zerbib, Pierre Desreumaux, Benoît Foligné, and Marie Titécat.
2024. "Changes in HLA-B27 Transgenic Rat Fecal Microbiota Following Tofacitinib Treatment and Ileocecal Resection Surgery: Implications for Crohn’s Disease Management" International Journal of Molecular Sciences 25, no. 4: 2164.
https://doi.org/10.3390/ijms25042164
APA Style
Blondeaux, A., Valibouze, C., Speca, S., Rousseaux, C., Dubuquoy, C., Blanquart, H., Zerbib, P., Desreumaux, P., Foligné, B., & Titécat, M.
(2024). Changes in HLA-B27 Transgenic Rat Fecal Microbiota Following Tofacitinib Treatment and Ileocecal Resection Surgery: Implications for Crohn’s Disease Management. International Journal of Molecular Sciences, 25(4), 2164.
https://doi.org/10.3390/ijms25042164
